Revelation Biosciences Stock Buy Hold or Sell Recommendation
| REVB Stock | USD 3.79 0.39 9.33% |
Given the investment horizon of 90 days and your complete indifference towards market risk, our recommendation regarding Revelation Biosciences is 'Hold'. Macroaxis provides Revelation Biosciences buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding REVB positions.
Check out Revelation Biosciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Revelation Stock refer to our How to Trade Revelation Stock guide. In addition, we conduct extensive research on individual companies such as Revelation and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Revelation Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
Revelation |
Execute Revelation Biosciences Buy or Sell Advice
The Revelation recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Revelation Biosciences. Macroaxis does not own or have any residual interests in Revelation Biosciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Revelation Biosciences' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Very Weak | Details | |
Volatility | Very risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Moves totally opposite to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Very Weak | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Revelation Biosciences Trading Alerts and Improvement Suggestions
| Revelation Biosciences generated a negative expected return over the last 90 days | |
| Revelation Biosciences has high historical volatility and very poor performance | |
| Revelation Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Revelation Biosciences currently holds 5.56 M in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Revelation Biosciences has a current ratio of 0.67, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Revelation Biosciences' use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (120.25 K) with profit before overhead, payroll, taxes, and interest of 90.91 M. | |
| Revelation Biosciences currently holds about 3.48 M in cash with (7.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.15. | |
| Revelation Biosciences has a very weak financial position based on the latest SEC disclosures | |
| Latest headline from businesswire.com: Revelation Biosciences, Inc. Receives Continued NASDAQ Listing Approval |
Revelation Biosciences Returns Distribution Density
The distribution of Revelation Biosciences' historical returns is an attempt to chart the uncertainty of Revelation Biosciences' future price movements. The chart of the probability distribution of Revelation Biosciences daily returns describes the distribution of returns around its average expected value. We use Revelation Biosciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Revelation Biosciences returns is essential to provide solid investment advice for Revelation Biosciences.
| Mean Return | -1.05 | Value At Risk | -15.43 | Potential Upside | 17.05 | Standard Deviation | 10.93 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Revelation Biosciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Revelation Stock Institutional Investors
| Shares | Xtx Topco Ltd | 2024-12-31 | 49.8 K | Hrt Financial Llc | 2024-09-30 | 0.0 | Sabby Management Llc | 2024-09-30 | 42.2 K | Two Sigma Securities, Llc | 2024-12-31 | 29.1 K | Tower Research Capital Llc | 2024-12-31 | 2.5 K | Sbi Securities Co Ltd | 2024-12-31 | 301 | Royal Bank Of Canada | 2024-12-31 | 100.0 | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 6.0 | Susquehanna International Group, Llp | 2024-12-31 | 0.0 | Pom Investment Strategies, Llc | 2024-12-31 | 0.0 | Bank Of America Corp | 2024-12-31 | 0.0 |
Revelation Biosciences Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Capital Expenditures | 861K | 526K | 132.0K | 4.0 | 3.6 | 3.42 | |
| Net Income | (1.6M) | (12.0M) | (10.8M) | (120.3K) | (108.2K) | (102.8K) | |
| Investments | (294.9M) | (368.6M) | (132.0K) | 16.2K | 18.6K | 19.5K | |
| Change In Cash | (74.2M) | (3.2M) | 4.0M | 6.7M | 6.1M | 5.8M | |
| End Period Cash Flow | 11.7K | 1.3M | 5.3M | 12.0M | 10.8M | 14.8M |
Revelation Biosciences Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Revelation Biosciences or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Revelation Biosciences' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Revelation stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -1.07 | |
β | Beta against Dow Jones | -0.87 | |
σ | Overall volatility | 11.60 | |
Ir | Information ratio | -0.1 |
Revelation Biosciences Volatility Alert
Revelation Biosciences is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Revelation Biosciences' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Revelation Biosciences' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Revelation Biosciences Fundamentals Vs Peers
Comparing Revelation Biosciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Revelation Biosciences' direct or indirect competition across all of the common fundamentals between Revelation Biosciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Revelation Biosciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Revelation Biosciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Revelation Biosciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Revelation Biosciences to competition |
| Fundamentals | Revelation Biosciences | Peer Average |
| Return On Equity | -2.7 | -0.31 |
| Return On Asset | -0.51 | -0.14 |
| Current Valuation | (4.29 M) | 16.62 B |
| Shares Outstanding | 522.28 K | 571.82 M |
| Shares Owned By Insiders | 0.10 % | 10.09 % |
| Shares Owned By Institutions | 11.80 % | 39.21 % |
| Number Of Shares Shorted | 63.43 K | 4.71 M |
| Price To Earning | 8.69 X | 28.72 X |
| Price To Book | 0.84 X | 9.51 X |
| Price To Sales | 2.88 X | 11.42 X |
| Gross Profit | 90.91 M | 27.38 B |
| EBITDA | (95.21 K) | 3.9 B |
| Net Income | (120.25 K) | 570.98 M |
| Cash And Equivalents | 3.48 M | 2.7 B |
| Cash Per Share | 0.15 X | 5.01 X |
| Total Debt | 5.56 M | 5.32 B |
| Debt To Equity | 0.01 % | 48.70 % |
| Current Ratio | 0.68 X | 2.16 X |
| Book Value Per Share | 9.97 X | 1.93 K |
| Cash Flow From Operations | (7.29 M) | 971.22 M |
| Short Ratio | 0.13 X | 4.00 X |
| Earnings Per Share | (280.48) X | 3.12 X |
| Target Price | 170.73 | |
| Number Of Employees | 9 | 18.84 K |
| Beta | 0.19 | -0.15 |
| Market Capitalization | 2.18 M | 19.03 B |
| Total Asset | 12.21 M | 29.47 B |
| Retained Earnings | (25.47 M) | 9.33 B |
| Working Capital | 6.58 M | 1.48 B |
| Net Asset | 12.21 M |
Note: Acquisition by Tidmarsh George F of 181 shares of Revelation Biosciences at 3.87 subject to Rule 16b-3 [view details]
Revelation Biosciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Revelation . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Revelation Biosciences Buy or Sell Advice
When is the right time to buy or sell Revelation Biosciences? Buying financial instruments such as Revelation Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Revelation Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Consumer Funds Thematic Idea Now
Consumer Funds
Funds or Etfs that invest in consumer products such as packaged goods, clothing, food, beverages and retail services. The Consumer Funds theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Consumer Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Revelation Biosciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Revelation Stock refer to our How to Trade Revelation Stock guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Revelation Biosciences. If investors know Revelation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Revelation Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Revelation Biosciences is measured differently than its book value, which is the value of Revelation that is recorded on the company's balance sheet. Investors also form their own opinion of Revelation Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Revelation Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Revelation Biosciences' market value can be influenced by many factors that don't directly affect Revelation Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Revelation Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Revelation Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Revelation Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.